Physician

Abdo Balikcioglu, MD

According to 2025 Medicare claims, Abdo Balikcioglu, MD (NPI: 1457366015) practices internal medicine in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. This provider's primary affiliated billing organization is PRIME QUALITY MEDICAL CARE PC (NPI: 1912033184; TIN: 113436667) and primary practice location at 11234-2625.

Balikcioglu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 163 traditional Medicare patients, billed 1,576 HCPCS/CPT codes, and received $132,252 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,687 prescription claims across 128 beneficiaries totaling $223,069 in drug costs, led by Eliquis (Apixaban). DME data shows 36 claims. Open Payments data shows 3 records totaling $78. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $185,229 and ending at $132,252. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $76,034 to $223,069. In contrast, DME billing represents a smaller volume and rose steadily, from $530 to $876.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	301	1,899	$185,229
2016	268	1,469	$138,941
2017	328	1,690	$165,514
2018	350	2,234	$197,335
2019	329	2,432	$208,250
2020	273	2,171	$185,110
2021	296	1,826	$147,470
2022	249	1,820	$139,594
2023	270	3,021	$266,164
2024	163	1,576	$132,252

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	129	953	$76,034
2016	137	1,044	$85,289
2017	262	1,153	$191,343
2018	152	998	$92,437
2019	192	1,064	$111,365
2020	139	983	$101,629
2021	218	1,174	$129,438
2022	233	1,387	$137,474
2023	140	1,576	$240,396
2024	128	1,687	$223,069

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	42	$459
2016	N/R	N/R	N/R
2017	N/R	15	$215
2018	N/R	N/R	N/R
2019	N/R	13	$202
2020	N/R	12	$589
2021	N/R	22	$830
2022	N/R	24	$724
2023	N/R	36	$1,065
2024	N/R	36	$409

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	80	93	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	52	106	$101
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	86	493	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	42	85	$76
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	62	329	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	39	2,610	$50,619
Jardiance	Empagliflozin	42	2,550	$45,827
Ozempic	Semaglutide	28	1,074	$27,132
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	480	$9,904
Pantoprazole Sodium	Pantoprazole Sodium	124	8,193	$1,489

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0003	Lightweight wheelchair	Y	N/R	12	$208
E0181	Powered pressure reducing mattress overlay/pad, alternating, with pump, includes heavy duty	Y	N/R	12	$118
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	N	N/R	12	$82

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$78	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdo Balikcioglu, MD?

Tedicare shows public-source Medicare data for Abdo Balikcioglu, MD (NPI 1457366015), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdo Balikcioglu, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdo Balikcioglu, MD?

Abdo Balikcioglu, MD is linked to PRIME QUALITY MEDICAL CARE PC (billing NPI 1912033184) in the available physician profile data.

Does Abdo Balikcioglu, MD have Open Payments data?

Abdo Balikcioglu, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.